General Information of Disease (ID: DISWZUF2)

Disease Name Glycogen storage disease VII
Synonyms
muscle phosphofructokinase deficiency; GSD 7; glycogen storage disease 7; glycogen storage disease due to muscle phosphofructokinase deficiency; GSD7; Pfkm deficiency; glycogen storage disease caused by mutation in PFKM; glycogen storage disease type 7; GSD due to muscle phosphofructokinase deficiency; glycogenosis type VII; glycogen storage disease type VII; phosphofructokinase deficiency; GSD type 7; Tarui disease; glycogenosis due to muscle phosphofructokinase deficiency; PFKM glycogen storage disease; GSDVII; Glycogen Storage Disease Type 7; glycogen storage disease VII; glycogen storage disease, type VII; GSD type VII; glycogenosis type 7; phosphofructokinase myopathy
Definition
Muscle phosphofructokinase (PFK) deficiency (Tarui's disease), or glycogen storage disease type 7 (GSD7), is a rare form of glycogen storage disease characterized by exertional fatigue and muscular exercise intolerance. It occurs in childhood.
Disease Hierarchy
DIS487SI: Hereditary haemolytic anemia
DIS0Y78V: Anemia due to erythrocyte enzyme disorder
DISYGNOB: Disorder of glycogen metabolism
DIS30PPZ: Disorder of glycolysis
DISWZUF2: Glycogen storage disease VII
Disease Identifiers
MONDO ID
MONDO_0009295
MESH ID
D006014
UMLS CUI
C0017926
OMIM ID
232800
MedGen ID
5342
Orphanet ID
371
SNOMED CT ID
89597008

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
PYGM TTZHY6R Strong Genetic Variation [1]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
AMPD3 OT5SP1KJ Strong Biomarker [2]
BRAP OTB7BAFQ Strong Altered Expression [2]
IMPA1 OTBUVW1Z Strong Altered Expression [2]
PFKM OT1QY9JM Definitive Autosomal recessive [3]
------------------------------------------------------------------------------------

References

1 Glycogen storage diseases in animals and their potential value as models of human disease.J Inherit Metab Dis. 1983;6(1):3-16. doi: 10.1007/BF02391186.
2 The contribution of Ca+ calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency.Haematologica. 2006 May;91(5):652-5.
3 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.